Dr Baswati Sahoo is a cataract and glaucoma surgeon with over 15 years experience in Ophthalmology in India and the United Arab Emirates.
An academic and teacher by nature, she is the recipient of the A. D. Patwardhan Gold medal from Pune University for excelling in Ophthalmology.
A thorough clinician with empathy towards her patients, she is held in high regard among her colleagues and her patients, for her professional acumen and skills. Her ability to understand and relate well, particularly with older people, hails from her training in Health Care of the Elderly.
Baswati worked as a General Practitioner in the Indian Air Force for almost six years. She is a sub-specialist in Glaucoma and Anterior Segment and has special training in complicated cataract and glaucoma surgery. Baswati is a Consultant at Hawkes Bay Hospital.
Baswati is a member of the Royal College of Surgeons, Glasgow. She has a masters in Ophthalmology from the Armed Forces Medical College of Pune, India. A keen learner with an open mind and aptitude for research, she was awarded the Senior Research Fellowship from the Indian Council of Medical Research, New Delhi.
She completed a long-term fellowship in Glaucoma and anterior segment at Shroffs Eye Hospital, New Delhi where she worked as a consultant before moving to the United Arab Emirates.
During this tenure, she was involved in the fellowship training programmes. Baswati was the Head of Ophthalmology in Ahalia Hospital, Abudhabi for five years and during this period the department showed remarkable progress, expanding its chain of eye hospitals in Abu Dhabi.
Born and brought up in India, Baswati completed her Masters in Ophthalmology from Armed Forces Medical College, Pune and Fellowship in Glaucoma and Anterior segment from Dr Shroff’s Eye Hospital, New Delhi.
A born leader, administrator, and problem solver, she believes in being a trend setter. A crowd puller, she has presented in many national and international conferences. Her Positive positive attitude towards life and everlasting smile has been a source of inspiration to many.
Being a retired Indian Air Force Officer makes her highly disciplined and punctual with great a strong sense of professional and social etiquette’s.
Travel: Baswati has travelled worldwide exploring parts of Europe and India. Music: Passionate about Bollywood music and recently trying her hands at the piano. Cooking: Takes pride in her culinary skills and loves to cook a meal for family and friends.
Baswati has published many papers in reputed journals and has been part of several clinical trials. The various conferences conducted by her successfully, speaks highly of her excellent organizational organisational skills.
She has authored a chapter on the Role of Optical Coherence Tomography in the evaluation Evaluation and management Management of glaucoma Glaucoma in the textbook – OCT IN OPHTHALMOLOGY.
1. IOP changes following DSEK: Letter to Editor: Ophthalmology Volume 117, Number 7, July 2010.
2. Conjunctival erosion after glaucoma drainage device surgery: A feasible option: IJO, Vol 61, 2013.
3. Revision of dysfunctional filtering bleb by conjunctival advancement with bleb preservation: A simple choice for massive choroidals with hypotony following trabeculectomy : Saudi Journal of Ophthalmology (2013) 27, 287—290.
4. Pigmentary Glaucoma: An Unusual Association with Wagner Syndrome. Adv Ophthalmol Vis Syst 2015, 2(2): 00035.
5. Infectious Scleritis Following Extracapsular Cataract Surgery with Trabeculectomy. EC Ophthalmology 2.1 (2015): 37-41. Clinical Trials : Was a co-investigator in the following trials:
ALLERGAN: Multicenter, Open label study of the Efficacy and safety of Triple Combination Therapyof 2.0% Dorzolamide hydrochloride/0.2% Brimonidine Tartarate/0.5% Timolol Ophthalmic Combination Administered Twice Daily in Patients with Glaucoma or Ocular Hypertension With Elevated IOP and on Dual Combination Therapy of Twice Daily Dorzolamide hydrochloride-Timolol maleate Ophthalmic Combination: Sponsor-ALLERGAN.
ALCON: Efficacy and Safety assessment of Latanoprost (0.005% , Unpreserved eye drops) versus Xalatan in Ocular Hypertensive or Glaucomatous Patients: Sponsor ALCON.